Table 1. List of uCMS-Induced Transcriptional Alterations Reversed by Antidepressants (ADs) Treatment.
| Probe set | Gene symbol or ID |
Fold change |
||||
|---|---|---|---|---|---|---|
| uCMS-exposed | FLX-treated | IMIP-treated | TIAN-treated | AGOM-treated | ||
| 10764367 | Mir181b-1 | 1.49 | — | −1.62 | −1.52 | — |
| 10887050 | Mir411 | 1.29 | −1.55 | −1.61 | −1.43 | — |
| 10887104 | Mir409 | 1.29 | −1.44 | −1.44 | −1.44 | −1.52 |
| 10816485 | Mir9-1 | 1.29 | — | −1.27 | — | — |
| 10887110 | Mir410 | 1.23 | −1.36 | — | −1.24 | — |
| 10887048 | Mir379 | 1.21 | −1.47 | −1.34 | — | — |
| 10863679 | Cml5 | 1.35 | — | — | −1.41 | −1.76 |
| 10732652 | Dusp1 | 1.32 | −1.47 | −1.53 | −1.61 | — |
| 10725778 | Nupr1 | 1.31 | — | — | −1.31 | — |
| 10799977 | Enkur | 1.23 | −1.23 | — | −1.34 | — |
| 10719648 | Zfp61 | 1.23 | — | — | — | −1.28 |
| 10864918 | Ret | 1.21 | — | — | — | −1.31 |
| 10828841 | Rab44 | −1.22 | — | — | 1.24 | — |
| 10809406 | Mt4 | −1.23 | 1.25 | 1.24 | 1.25 | — |
| 10712196 | Pkp3 | −1.24 | — | — | 1.21 | — |
| 10722273 | Fancf | −1.27 | 1.22 | — | 1.22 | — |
| 10747214 | Krt31 | −1.29 | — | — | 1.28 | 1.27 |
| 10759553 | Lrrc8e | −1.40 | — | 1.29 | 1.43 | 1.42 |
| 10731444 | Rsl1d1 | −1.71 | — | — | — | 1.41 |
| 10788070 | ENSRNOT00000059482 | −1.47 | 1.59 | 1.61 | 1.54 | 1.48 |
| 10806413 | ENSRNOT00000060679 | −1.34 | — | 1.44 | 1.49 | — |
| 10767075 | ENSRNOT00000053847 | −1.38 | 1.52 | — | 1.48 | — |
| 10722578 | ENSRNOT00000055917 | −1.38 | — | 1.39 | 1.42 | — |
| 10752628 | ENSRNOT00000063656 | −1.42 | 1.41 | — | — | — |
| 10775226 | ENSRNOT00000047758 | −1.43 | 1.42 | 1.50 | — | — |
| 10755670 | ENSRNOT00000053925 | −1.57 | — | 1.94 | 2.15 | — |
| 10749818 | ENSRNOT00000053950 | −1.66 | 2.04 | 1.73 | 1.85 | — |
| 10785624 | ENSRNOT00000057823 | −1.22 | 1.23 | — | — | — |
| 10763318 | ENSRNOT00000049616 | −1.24 | 1.28 | 1.27 | — | — |
| 10744141 | ENSRNOT00000054292 | −1.25 | — | — | 1.24 | — |
| 10780922 | ENSRNOT00000032631 | −1.25 | 1.26 | — | 1.38 | 1.34 |
| 10857470 | ENSRNOT00000056864 | −1.26 | — | 1.25 | — | — |
| 10702579 | ENSRNOT00000060826 | −1.27 | 1.32 | 1.30 | 1.36 | — |
| 10724150 | ENSRNOT00000031043 | −1.28 | — | — | 1.22 | — |
| 10707740 | ENSRNOT00000055911 | −1.29 | 1.30 | 1.34 | 1.34 | — |
| 10873723 | LOC100360708 | 1.28 | — | −1.38 | −1.43 | — |
| 10744306 | LOC497940 | 1.24 | −1.26 | — | — | — |
| 10926285 | LOC680955 | 1.21 | — | — | −1.28 | — |
| 10805591 | LOC689153 | −1.26 | 1.22 | — | 1.35 | 1.44 |
| 10937658 | LOC686031 | −1.58 | 1.58 | 1.48 | 1.48 | 1.56 |
| 10783022 | RGD1310110 | 1.25 | — | — | — | — |
| 10726241 | RGD1560958 | −1.29 | 1.22 | — | 1.22 | — |
| 10817543 | FQ225205 | −1.87 | 2.10 | — | — | — |
| Percentage of reversed alterations | — | 25 | 22 | 33 | 12 | |
Last row shows the percentage of molecules whose expression was reversed by each of the ADs.